4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-024196
CHIEF OPERATING OFFICER sold 6,667 shares at $20.24 ($134,957)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Anish CHIEF OPERATING OFFICER | 2025-09-08 | Sale 10b5-1 | −6,667 | $20.24 | $134,957 | 283,308 | I |
| Open-market sales · 6,667 sh · avg $20.24 · $134,957 | |||||||
Loading xslF345X05/form4-09112025_120931.xml…